fashion -WSS

fashion

author：hotspot 2025-09-06 04:41:59 - browse：95

Sammy Kimball for STAT

Why do CEOs talk like that? Do biotech stock tips make good gifts? And what do Anthony Fauci and Stéphane Bancel have in common?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss why Wall Street was less than convinced by Biogen’s attempt to assuage concerns about its credibility. Then we explain an insider trading scandal that bridges biotech and elite-level soccer, the latest concerns over Wegovy, and the rest of the week’s news in the life sciences. We also break some bittersweet news, with the help of some headline names from around biotech.

For more on what we cover, here’s the Biogen news; here are the charges against Joe Lewis; here’s the latest on Wegovy; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare details structure of new drug price negotiation program
Next article： 'Null' research findings aren't empty of meaning. Let's publish them

entertainment

WSS

It costs an awful lot of money to give away a kidney

H.R. 3 is the wrong path to lower drug costs

RaDonda Vaught links Vanderbilt hospital issues to patient death

FDA approves Sage Therapeutics’ rapid

Study links childhood stress with decline in older age

Physicians aren't 'burning out.' They're suffering from moral injury

knowledge

fashion

focus

Jerome Adams on the need for new antivirals for Covid

Physicians aren't 'burning out.' They're suffering from moral injury

Malaria cases in Florida and Texas: Here’s what you need to know

FDA advisers back CAR

Virginia high school admissions case could be legal follow

Medicare coverage of Wegovy, once blocked, now looks possible

How to save PrEP access — and even expand it

FDA approves Sage Therapeutics’ rapid

Trump demands the U.S. pay no more for drugs than other countries … again

EPA limits use of carcinogenic gas for sterilizing medical devices

entertainment

It costs an awful lot of money to give away a kidney

Change Healthcare outage fallout shows need for new oversight

When waiting feels immoral: Empathy in the emergency department

WuXi out of biotech trade group, U.S. and China relations to blame

Ebola: Gilead Sciences antiviral shows promise as new treatment

FDA approves Sage Therapeutics’ rapid

leisure time

entertainment

explore

knowledge